Description
This study is evaluating an oral investigational medication for patients who have Ewing sarcoma, Myxoid liposarcoma, Clear cell sarcoma, Desmoplastic Small Round cell tumor or a related sarcoma that has returned or has not responded to treatment.
An individual may qualify for the study if they:
Are 12 years of age or older
Have been diagnosed with Ewing sarcoma, Myxoid liposarcoma, Clear cell sarcoma, Desmoplastic Small Round cell tumor or another type of sarcoma that may be related to Ewing sarcoma
Sarcoma must have returned or not responded to last treatment
Have received at least 1 prior therapy for sarcoma
Meet additional study criteria
Reimbursement for reasonable, out-of-pocket expenses for travel and accommodations may be available to qualified individuals.
To learn more about the clinical trial and to see if you may qualify, please visit our website at sala-002-ew16.researchstudytrial.com?&r=5
More information about this study can be found at https://clinicaltrials.gov/ct2/show/NCT03600649
Discussion
By posting you agree to the Terms and Privacy Policy.